Author:
Bijker Rimke,Choi Jun Yong,Ditangco Rossana,Kiertiburanakul Sasisopin,Lee Man Po,Siwamogsatham Sarawut,Pujari Sanjay,Ross Jeremy,Wong Chi-yuen,Wong Wing-Wai,Yunihastuti Evy,Law Matthew
Abstract
Introduction:
Cardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region.
Materials and Methods:
We provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region.
Results:
Studies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope.
Conclusion:
Development and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIV-positive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.
Publisher
Bentham Science Publishers Ltd.
Subject
Virology,Infectious Diseases,Public Health, Environmental and Occupational Health
Reference54 articles.
1. Deeks SG, Lewin SR, Havlir DV.
The end of AIDS: HIV infection as a chronic disease.
Lancet
2013;
382
(9903)
: 1525-33.
2. Martin-Iguacel R, Llibre JM, Friis-Moller N.
Risk of cardiovascular disease in an aging HIV population: where are we now?
Curr HIV/AIDS Rep
2015;
12
(4)
: 375-87.
3. Helleberg M, Kronborg G, Larsen CS, et al.
CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV.
Clin Infect Dis
2013;
57
(2)
: 314-21.
4. Study D.
The Data Collection on Adverse Events of Anti-HIV drugs Study Group. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:
AIDS
2010;
24
: 1537-48.
5. Nou E, Lo J, Grinspoon SK.
Inflammation, immune activation, and cardiovascular disease in HIV.
AIDS
2016;
30
(10)
: 1495-509.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献